TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

South Korea · Delayed Price · Currency is KRW

2,265.00

-130.00 (-5.43%)

Oct 8, 2026, 3:30 PM KST

Market Cap	12.73B -68.8%
Revenue (ttm)	61.78B +50.6%
Net Income	-17.48B
EPS	-2,860.86
Shares Out	5.62M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,885
Open	2,355.00
Previous Close	2,395.00
Day's Range	2,260.00 - 2,355.00
52-Week Range	1,700.00 - 13,210.00
Beta	0.38
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About TELCON RF PHARMACEUTICAL.

TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1999

Employees 126

Stock Exchange KOSDAQ

Ticker Symbol 200230

Full Company Profile

Financial Performance

In 2025, TELCON RF PHARMACEUTICAL.'s revenue was 43.16 billion, an increase of 13.99% compared to the previous year's 37.87 billion. Losses were -11.46 billion, -56.48% less than in 2024.

Financial Statements